Deutsche Bank Upgrades Persimmon to Buy After Strong First-Half Results 
OpenAI Restricts Astra AI Over Cyberattack Risks 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
Daimler Truck Q2 Profit Falls 18%, 2026 Outlook Raised 
Sony, TSMC Eye $6.3 Billion Japan Chip Venture for Next-Gen Image Sensors 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Berkshire Hathaway Cash Falls as Abel Boosts Stock Buybacks 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
AMP Shares Surge 13% After Strong Profit and A$150 Million Buyback 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
Shein Scales Back Vietnam Operations as US Trade Rules Shift 
SK Hynix, Samsung Lead Asian Chip Stock Selloff After Sandisk, Western Digital Outlook 
Delta Flight Makes Emergency Landing in Atlanta After Cockpit Fumes Reported 
MINNEAPOLIS, Feb. 21, 2018 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the BTIG Healthcare Conference at The Cliff Lodge in Snowbird, UT. Management will attend on Wednesday, February 28 and participate in investor meetings. There will be no formal presentation to investors.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Our mission is to help people suffering from chronic diseases live better and care for themselves at home. Our unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
Investor Inquiries:
Mike Piccinino, CFA
Managing Director
Westwicke Partners
443-213-0500
[email protected]
